- Home
- CING vs ICMB Comparison
CING vs ICMB Comparison
Compare CING & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CING | ICMB |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | 13 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 38.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CING | ICMB |
|---|---|---|
| Price | $5.69 | $2.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | ★ 191.0K | 24.7K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 18.37% |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $17,931,778.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.75 |
| P/E Ratio | ★ N/A | $7.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.20 | $2.46 |
| 52 Week High | $6.01 | $3.47 |
Technical Indicators
Market Signals| Indicator | CING | ICMB |
|---|---|---|
| Relative Strength Index (RSI) | 74.12 | 60.23 |
| Support Level | $4.83 | $2.74 |
| Resistance Level | $5.07 | $2.78 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 94.57 | 100.00 |
Price Performance
Historical ComparisonAbout CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.